Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan · Delayed Price · Currency is TWD 50.10
-0.80 (-1.57%)
At close: Nov 10, 2026
Yoda Pharmaceuticals Market Cap
Yoda Pharmaceuticals has a market cap or net worth of 4.98 billion as of November 9, 2026. It is the 23,584th most valuable company in the world and the 1,179th biggest in Taiwan. Its market cap has increased by 0.84% in one year.
Market Cap
4.98B
Enterprise Value
3.59B
Revenue
n/a
Global Rank
Country Rank
#1,179 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 3, 2025, Yoda Pharmaceuticals's market cap has increased from 2.92B to 4.98B, an increase of 70.67%. That is a compound annual growth rate of 45.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 4.98B | 7.03% |
| Dec 31, 2025 | 4.65B | 59.46% |
| Jun 3, 2025 | 2.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 9.88B |
| SCI Pharmtech | 5.92B |
| Orient Pharma | 5.35B |
| Formosa Laboratories | 5.26B |
| Alar Pharmaceuticals | 4.93B |
| LIWANLI Innovation | 4.35B |
| Panion & Bf Biotech | 4.20B |
| Orient EuroPharma | 3.67B |